F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
about
Mechanistic Approaches to Improve Correction of the Most Common Disease-Causing Mutation in Cystic FibrosisTherapeutic Effects of α1-Antitrypsin on Psedumonas aeruginosa Infection in ENaC Transgenic Mice.Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.Novel CFTR Mutations in Two Iranian Families with Severe Cystic Fibrosis.Can Cystic Fibrosis Patients Finally Catch a Breath With Lumacaftor/Ivacaftor?
P2860
F508del-cystic fibrosis transmembrane regulator correctors for treatment of cystic fibrosis: a patent review.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@ast
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@en
type
label
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@ast
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@en
prefLabel
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@ast
F508del-cystic fibrosis transm ...... tic fibrosis: a patent review.
@en
P2860
P1476
F508del-cystic fibrosis transm ...... stic fibrosis: a patent review
@en
P2093
P2860
P304
P356
10.1517/13543776.2015.1045878
P407
P50
P577
2015-05-15T00:00:00Z